New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 28, 2013
10:15 EDTAKS, STT, WY, BWA, INGR, CELG, OSK, VNO, F, RBS, SCCO, NE, AAPL, BBBY, GLW, EEP, ENR, IMGN, JOY, LIFE, NYX, JOSBOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AK Steel (AKS) downgraded to Sell from Neutral at Goldman... Apple (AAPL) downgraded to Neutral from Outperform at RW Baird... Bed Bath & Beyond (BBBY) downgraded to Sell from Neutral at Goldman... Brookfield Properties (BPO) downgraded to Sell from Neutral at Citigroup... Corning (GLW) downgraded to Equal Weight from Overweight at Barclays... Enbridge Energy (EEP) downgraded to Market Perform from Outperform at Wells Fargo... Energizer (ENR) downgraded to Equal Weight from Overweight at Morgan Stanley... ImmunoGen (IMGN) downgraded to Perform from Outperform at Oppenheimer... Joy Global (JOY) downgraded to Market Perform from Outperform at Raymond James... Life Technologies (LIFE) downgraded to Neutral from Buy at UBS... NYSE Euronext (NYX) downgraded to Neutral from Buy at UBS... Noble Corp. (NE) downgraded to Equal Weight from Overweight at Stephens... Southern Copper (SCCO) downgraded to Underweight from Hold at BB&T... State Street (STT) downgraded to Market Perform from Outperform at Keefe Bruyette... Weyerhaeuser (WY) downgraded to Sector Perform from Outperform at RBC Capital... BorgWarner (BWA) downgraded to Neutral from Buy at Sterne Agee... Ingredion (INGR) downgraded to Neutral from Buy at Citigroup... Celgene (CELG) downgraded to Hold from Buy at Argus... Oshkosh (OSK) downgraded to Neutral from Buy at Longbow... Vornado (VNO) downgraded to Cautious from Neutral at ISI Group... Ford (F) downgraded to Underperform from Neutral at Buckingham... Royal Bank of Scotland (RBS) downgraded to Sell from Neutral at Goldman... JoS. A. Bank (JOSB)downgraded to Equal Weight from Overweight at Johnson Rice.
News For AKS;AAPL;BBBY;GLW;EEP;ENR;IMGN;JOY;LIFE;NYX;NE;SCCO;STT;WY;BWA;INGR;CELG;OSK;VNO;F;RBS;JOSB From The Last 14 Days
Check below for free stories on AKS;AAPL;BBBY;GLW;EEP;ENR;IMGN;JOY;LIFE;NYX;NE;SCCO;STT;WY;BWA;INGR;CELG;OSK;VNO;F;RBS;JOSB the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | all recent news | >>
July 9, 2014
16:01 EDTAAPLOptions Update; July 9, 2014
Subscribe for More Information
12:54 EDTAAPLGarmin tumbles after analyst sees risk from GoPro, Apple products
Subscribe for More Information
11:57 EDTCELGCelgene shares higher despite missing primary endpoint in Otezla trial
Subscribe for More Information
11:36 EDTENREnergizer poised to move higher after breakup, Barron's reports
Subscribe for More Information
10:51 EDTSTTState Street, others reach $60M settlement over forex services, Reuters says
State Street and other defendants agreed to settle a lawsuit accusing them of overcharging clients for foreign exchange services for $60M, according to Reuters, citing a court filing. The report notes that the proposed settlement requires approval by federal judge. Reference Link
10:20 EDTAAPLReport says Intel delaying Broadwell chip shipment, MacRumors says
Intel (INTC) has decided to further postpone the shipping of its line of 14-nanometer Broadwell chips, which are anticipated to be included in future versions of the Apple's (AAPL) MacBook Air, Retina MacBook Pro, and iMac, according to MacRumors, citing a report on Chinese site VR Zone. Reference Link
09:47 EDTFNew car sales in India rose 15% in June, WSJ reports
Subscribe for More Information
09:35 EDTCELG, AAPLActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL AA FB AMZN TSLA TWTR MU NFLX GG CELG
09:13 EDTCELGOn The Fly: Pre-market Movers
Subscribe for More Information
09:07 EDTVNOVornado completes sale of Beverly Connection Shopping Center for $260M
Subscribe for More Information
07:45 EDTAAPLCostco selling Apple products again, says Jefferies
Jefferies says that starting in late June, Costco (COST) began selling Apple (AAPL) products in stores and online again, after not carrying the brand since 2010. The firm thinks the move will help Costco's weaker performing Consumer Electronics category. Jefferies expects Costco to report a June comp store sales increase of 5%-6% and keeps a Hold rating on the stock.
07:10 EDTAAPLApple price target raised to $105 from $90 at Mizuho
Mizuho expects Apple to report an inline Q3 but sees upside to Q4 and expects revenue guidance to be $1B-$2B above consensus and EPS upside of 5c-10c. The firm expects 2H 2014 stock gains to be driven by the strong product cycle. Shares are Buy rated with a $105 price target, up from $90.
07:10 EDTAAPLDisney ceases on-demand movie sales in Japan via iTunes, Reuters says
Subscribe for More Information
07:04 EDTCELGCelgene says OTEZLA did not achieve primary endpoint in Phase III trial
Celgene Corporation announced results of its phase III POSTURE study evaluating OTEZLA, the company’s oral, selective inhibitor of phosphodiesterase 4, in patients with active ankylosing spondylitis. The OTEZLA arms did not achieve statistically significant improvement versus the placebo arm for the primary endpoint, the percentage of patients who achieve an ASAS 20 response at week 16. However, in a prespecified analysis, meaningful efficacy was observed at Week 24 in a large subset of patients with early-stage disease. Evaluation of the efficacy results is ongoing. An independent data monitoring committee recommended that the study proceed unchanged, based on an assessment of the safety and efficacy data at week 24. According to the protocol, magnetic resonance imaging data will be collected in a subgroup of subjects at week 52 and at additional time points, and radiographs will be taken on all study patients at week 104 and at additional time points. The safety and tolerability data observed in the POSTURE study are consistent with previously reported phase II data in ankylosing spondylitis, as well as six phase III studies of OTEZLA in psoriatic arthritis or psoriasis. No new safety signals were observed. The evaluation of safety and efficacy in the treatment arms is ongoing and the results of the study will be presented at an upcoming medical meeting. These results are from an investigational phase III study. OTEZLA is not approved for the treatment of patients with ankylosing spondylitis in any country.
06:58 EDTAAPLApple hires two Nike FuelBand engineers, Apple Insider erports
Subscribe for More Information
06:46 EDTAAPLApple loses patent suit in China, Reuters says
Apple (AAPL) had taken Shanghai-based Zhizhen Internet Technology and China's State Intellectual Property Office to court in hopes that the court would rule that Zhizhen's patent rights to a speech recognition technology were invalid, but the Beijing First Intermediate Court decided in favor of Zhizhen, according to Reuters, citing a report from the People's Daily state newspaper in China. After the ruling, the report noted that Apple is aiming to take the case to the Beijing Higher People's Court. Reference Link
06:34 EDTAAPLFake document hits federal court in hiring case against tech giants, WSJ says
Subscribe for More Information
06:31 EDTAAPLFTC may probe Google over child app purchases, Politico says
After the Federal Trade Commission cracked down on apps previously available on Apple (AAPL) devices that let children spend money without their parents' permission, Apple told the FTC that similar apps are available on Google's (GOOG) app store, according to Politico. As a result, the FTC may investigate Google over this issue, Politico stated. Reference Link
06:03 EDTBBBYStocks with implied volatility below IV index mean; LULU BBBY
Stocks with implied volatility below IV index mean; lululemon (LULU) 37, Bed Bath & Beyond (BBBY) 18.
05:54 EDTAAPLGarmin downgraded to Underperform from Sector Perform at Pacific Crest
Pacific Crest downgraded its rating on Garmin (GRMN) to Underperform saying any action camera optimism is likely to end in disappoint while Apple's (AAPL) potential watch announcement could create "substantial" headline and competitive risk. Pacific Crest believes Garmin shares may be overvalued and sees fair value for the stock in the mid-$40 range. The stock closed yesterday at $60.63.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use